SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

BenefitsRx Improves Medication Adherence

BenefitsRx Home Delivery Pharmacy Solution Maximizes Health Outcomes for its Members

WINNIPEG, March 6, 2014 /CNW/ - New research published in the American Journal of Managed Care shows that patients using home delivery are 11-19 percent more likely to be adherent to their drug therapy than similar patients who receive their medications through a retail pharmacy. With that in mind, BenefitsRx's proactive adherence program is intended to help patients keep to their medication programs.

"Poor medication adherence is a widespread issue for Canadians," said Paul Clark, president of BenefitsRx. "The reason for non-compliance of drug therapy range from concerns about side effects to high out-of-pocket costs."

The BenefitsRx adherence program proactively calls patients for refill reminders, arranges for renewals from the doctor, transfers prescriptions, and resolves any issues with the order prior to filling.

Adds Clark, "When integrated with other PBM services from BenefitsRx, home delivery can increase compliance, the use of generics and adherence to formulary structures."

BenefitsRx home delivery uses a high volume mail order fulfillment approach that streamlines the supply chain, improves accuracy, and significantly reduces the cost of production.

For plan sponsors, home delivery is an important element of an overall strategy for improving patient care and controlling plan costs. An effective home delivery program can save plan sponsors as much as 20 percent on their pharmacy benefit spend.

About BenefitsRx

BenefitsRx is a Canadian company dedicated to the needs of Canadian employers, unions, associations, or other groups looking to improve drug coverage for their members. The mission of the company is to achieve the best possible health outcomes for plan members with the most cost-effective drug therapies.

SOURCE BenefitsRx

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.